Biogen's stock jumps 30% after FDA staff says it has enough data to support approving Alzheimer's drug
November 04, 2020 at 10:51 AM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|